Nyumbani › Kasinoma ya Selu za Mpito (Urothelial) › Texas
Majaribio ya kliniki ya Kasinoma ya Selu za Mpito (Urothelial) katika jimbo la Texas
Masomo 38 ya Kasinoma ya Selu za Mpito (Urothelial) yanatafuta washiriki katika vituo vya jimbo la Texas.
Miji katika jimbo la Texas
- DallasUtafiti 18
- HoustonUtafiti 18
- San AntonioUtafiti 11
- AustinUtafiti 10
- The WoodlandsUtafiti 5
- Fort WorthUtafiti 5
- TylerUtafiti 4
- IrvingUtafiti 3
- League CityUtafiti 3
- Sugar LandUtafiti 3
Maandishi rasmi ya utafiti (Kiingereza)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- NEXT Austin, Austin
- START Center for Clinical Research, Fort Worth
- University of Texas MD Anderson Cancer Center, Houston
- na zaidi ya 1
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06270706Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #46, Austin
- Exelixis Clinical Site #89, Dallas
- Exelixis Clinical Site #73, Irving
- na zaidi ya 2
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT05176483A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- Houston Methodist San Jacinto Hospital, Baytown
- Houston Methodist Cypress Hospital, Cypress
- Parkland Memorial Hospital, Dallas
- na zaidi ya 10
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06524544A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center - Conroe, Conroe
- University of Texas MD Anderson Cancer Center, Houston
- The University of Texas, MD Anderson Cancer Center - West Houston, Houston
- na zaidi ya 3
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07090499Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Texas Oncology, Austin
- Texas Oncology - Northeast Texas, Tyler
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- na zaidi ya 1
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- UT Southwestern Medical Center, Dallas
- The University of Texas M.D. Anderson Cancer Center, Houston
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT05874921DBC-664 in Adult Patients With Solid Tumors
- START San Antonio, San Antonio
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07705035Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- na zaidi ya 13
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Dallas Fort Worth, Fort Worth
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
- na zaidi ya 1
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07277413Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Baylor, Scott and White Research Institute, Dallas
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06047379A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- USO-Texas Oncology-Central/South Texas, Austin
- World Research Link, Baytown
- Parkland Health and Hospital System, Dallas
- na zaidi ya 5
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07218380Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06439836A Study of GEN1106 in Participants With Solid Tumors
- South Texas Accelerated Research Therapeutics, San Antonio
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT07416123Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Start - Dfw, Fort Worth
- Oncology Consultants, Houston
- START - San Antonio, San Antonio
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT06293898A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- UPNT Research Institute, LLC, Arlington
- Texas Urology Specialists-Austin, Austin
- Houston Metro Urology (HMU) - Southwest Location, Houston
- na zaidi ya 3
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT06774131Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- START San Antonio, San Antonio
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT06582017Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Dallas
InaajiriHatua 2/3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT07129993Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
- NEXT Oncology, Austin, Austin
- NEXT Oncology, San Antonio, San Antonio
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT06966024A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Houston Methodist Hospital, Houston
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT04895709A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, San Antonio
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT07749586A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Texas Oncology - West Texas, Amarillo
- Texas Oncology, P.A., Dallas
- Texas Oncology Gulf Coast, Pearland
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Ago 2026 · NCT06330064Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- The University of Texas Health Science Center at Tyler, Tyler
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Jul 2026 · NCT04198766An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Dallas
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Jul 2026 · NCT07720284A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Baylor Scott and White Research Institute, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
- Baylor Scott & White Medical Center - Temple, Temple
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Jul 2026 · NCT04879329A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Texas Oncology - DFW, Dallas
- MD Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Jul 2026 · NCT06695845A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- MD Anderson Cancer Center, Houston
- Next Oncology-Oncology, San Antonio
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Jul 2026 · NCT07169734Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Austin Urology Institute, Austin
- UT Southwestern Medical Center, Dallas
Inaajiri
Umri 18 hadi 88 · Jinsia zote · Imesasishwa 2 Jul 2026 · NCT06394869Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
- UT Southwestern Medical Center, Dallas
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Jun 2026 · NCT07673016Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
- MDACC, Houston
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Jun 2026 · NCT07484022Bladder Cancer Screening Trial
- University of Texas Southwestern Medical Center, Dallas
Inaajiri
Umri 50 na zaidi · Jinsia zote · Imesasishwa 1 Mei 2026 · NCT05646485Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- M D Anderson Cancer Center, Houston
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Apr 2026 · NCT04693377This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- NEXT Oncology, Austin, TX 78758
- NEXT Oncology, San Antonio
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Apr 2026 · NCT06451497An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
- University of Texas Southwestern Medical Center, Dallas
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Jan 2026 · NCT04623502A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Austin
- Dren Investigational Site, Dallas
- Dren Investigational Site, San Antonio
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Jan 2026 · NCT06999187A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Des 2025 · NCT06943521SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 28 Okt 2025 · NCT03452774A Study of NX-1607 in Adults With Advanced Malignancies
- MD Anderson Cancer Center, Houston
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2025 · NCT05107674Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.